Emerging insights into the tumor microenvironment, immune resistance mechanisms, and T-cell subpopulation dynamics (e.g., γδ T cells, exhausted CD8+ T cells) are analyzed to elucidate immunotherapy response variability. The gene discussed is CD8A; the disease is neoplasm.